STOCK TITAN

Enlight (ENLT) executive exercises 35,286 options and sells 26,622 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enlight Renewable Energy executive Ilan Goren reported a mix of option exercises, tax withholding and share sales. He exercised 35,286 stock options at $23.22 per share, receiving ordinary shares. The company retained 8,664 shares to cover the option exercise price and related obligations. Goren then sold 26,622 ordinary shares in an open-market transaction at $103.76 per share. After these transactions, he holds 42,835 ordinary shares directly and maintains stock options over 98,743 shares at a $27.33 exercise price expiring on July 29, 2032, and 100,000 shares at a $22.17 exercise price expiring on June 28, 2029. Additional option and RSU positions are included for informational purposes without new transactions.

Positive

  • None.

Negative

  • None.
Insider Goren Ilan
Role GENERAL MANAGER, ENLIGHT US
Sold 26,622 shs ($2.76M)
Approx. gross sale proceeds $2.76M
Approx. exercise cost $819K
Type Security Shares Price Value
Exercise Stock Options (right to buy) 35,286 $0.00 $0.00
Exercise Ordinary shares, NIS 0.1 par value per share 35,286 $23.22 $819K
Exercise Price or Tax Liability Ordinary shares, NIS 0.1 par value per share 8,664 $103.76 $899K
Sale Ordinary shares, NIS 0.1 par value per share 26,622 $103.76 $2.76M
holding Stock Options (right to buy) -- -- --
holding Stock Options (right to buy) -- -- --
Holdings After Transaction: Stock Options (right to buy) — 228,457 shares (Direct); Ordinary shares, NIS 0.1 par value per share — 42,835 shares (Direct)
Footnotes (10)
  1. F1. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2. Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4. Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  5. F5. Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.
  6. F6. Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  7. F7. Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.
  8. F8. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  9. F9. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  10. F10. Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
Open-market sale 26,622 shares at $103.76 Ordinary shares sold on May 27, 2026
Options exercised 35,286 shares at $23.22 Stock option exercise on May 27, 2026
Tax-withholding shares 8,664 shares at $103.76 Shares delivered to company for exercise price/taxes
Shares held after 42,835 shares Direct ordinary share ownership following transactions
Remaining options 1 98,743 shares at $27.33 Stock options expiring July 29, 2032
Remaining options 2 100,000 shares at $22.17 Stock options expiring June 28, 2029
Stock Options (right to buy) financial
"security_title: "Stock Options (right to buy)""
restricted share units financial
"Includes (i) 14,083 restricted share units granted on April 21, 2024"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Bank of Israel representative exchange rate financial
"converted to U.S. dollars using the Bank of Israel representative exchange rate"
exercise price financial
"Represents an exercise price of NIS 71.89, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Enlight (ENLT) executive Ilan Goren report in this Form 4?

Ilan Goren reported exercising 35,286 stock options, a tax-withholding share disposition, and selling 26,622 Enlight ordinary shares. The filing also lists his remaining direct share ownership and substantial unexercised stock option positions with specified exercise prices and expiration dates.

How many Enlight (ENLT) shares did Ilan Goren sell and at what price?

He sold 26,622 Enlight ordinary shares in an open-market transaction at $103.76 per share. This sale followed an option exercise and a separate tax-withholding disposition in which additional shares were delivered to the company rather than sold in the market.

How many Enlight (ENLT) stock options did Ilan Goren exercise?

He exercised 35,286 stock options at an exercise price of $23.22 per share, receiving ordinary shares. A portion of the resulting shares was then used to cover the option exercise price and related obligations, and another portion was sold on the open market.

What is Ilan Goren’s Enlight (ENLT) shareholding after these transactions?

Following the reported transactions, Ilan Goren holds 42,835 Enlight ordinary shares directly. This figure reflects the net result after the option exercise, the tax-withholding disposition to the company, and the open-market sale of 26,622 ordinary shares.

What Enlight (ENLT) stock options does Ilan Goren still hold after the Form 4?

He retains stock options over 98,743 shares at a $27.33 exercise price expiring July 29, 2032 and options over 100,000 shares at a $22.17 exercise price expiring June 28, 2029. These positions provide significant remaining potential equity exposure.

Were all option and RSU positions in the Enlight (ENLT) Form 4 newly transacted?

No. One footnote explains certain securities are included for informational purposes only and that no transaction has been effected for those positions. They reflect existing holdings, not new purchases, sales, or exercises in this Form 4.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Goren Ilan

(Last)(First)(Middle)
C/O ENLIGHT RENEWABLE ENERGY LTD.
13 AMAL ST. AFEK INDUSTRIAL PARK

(Street)
ROSH HA'AYIN4802949

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enlight Renewable Energy Ltd. [ ENLT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
GENERAL MANAGER, ENLIGHT US
2a. Foreign Trading Symbol
[ENLT]
3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary shares, NIS 0.1 par value per share05/27/2026M35,286A$23.22(1)78,121(2)D
Ordinary shares, NIS 0.1 par value per share05/27/2026F8,664(3)D$103.76(4)69,457(2)D
Ordinary shares, NIS 0.1 par value per share05/27/2026S26,622D$103.76(4)42,835(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (right to buy)$23.22(1)05/27/2026M35,286 (5)09/30/2028Ordinary shares, NIS 0.1 par value per share35,286$029,714D
Stock Options (right to buy)$22.17(6) (7)06/28/2029Ordinary shares, NIS 0.1 par value per share100,000(8)100,000(8)D
Stock Options (right to buy)$27.33(9) (10)07/29/2032Ordinary shares, NIS 0.1 par value per share98,743(8)98,743(8)D
Explanation of Responses:
1. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
2. Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
3. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
4. Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
5. Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.
6. Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
7. Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.
8. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
9. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
10. Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
By: /s/ Helit Megido as attorney-in-fact for Ilan Goren05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)